Viewing StudyNCT00125827



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00125827
Status: COMPLETED
Last Update Posted: 2014-03-19
First Post: 2005-07-29

Brief Title: Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Solid Tumors
Keywords:
Name View
Clolar View
CLO152 View